Cannon Financial Strategists, Inc. Novartis Ag Transaction History

Cannon Financial Strategists, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 01, 2024	SELL	$95.27 - $108.47 $387,653 - $441,364	-4,069 Closed	0 $0
Q4 2023 Oct 01, 2024	BUY	$92.27 - $101.54 $375,446 - $413,166	4,069 New	4,069 $310 Million
Q3 2021 Oct 02, 2024	SELL	$81.78 - $95.14 $155,545 - $180,956	-1,902 Closed	0 $0
Q2 2021 Oct 02, 2024	BUY	$85.24 - $94.15 $162,126 - $179,073	1,902 New	1,902 $529 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Cannon Financial Strategists, Inc., based on Form 13F filings with the SEC.

Stay updated on Cannon Financial Strategists, Inc. with notifications on news.